125 related articles for article (PubMed ID: 6045352)
1. The use and abuse of oral hypoglycemic agents.
Sussman KE
Rocky Mt Med J; 1967 Feb; 64(2):56-9. PubMed ID: 6045352
[No Abstract] [Full Text] [Related]
2. Oral sulphonylureas in the management of diabetes.
Jackson WP
S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
[No Abstract] [Full Text] [Related]
3. Clinical pharmacology of oral antidiabetic agents (first of two parts).
Shen SW; Bressler R
N Engl J Med; 1977 Mar; 296(9):493-7. PubMed ID: 319363
[No Abstract] [Full Text] [Related]
4. Diabetes mellitus: the thin maturity-onset diabetic.
Br Med J; 1972 Sep; 3(5828):692-4. PubMed ID: 4631184
[No Abstract] [Full Text] [Related]
5. Oral hypoglycaemic drugs.
Br Med J; 1969 Mar; 1(5647):829-31. PubMed ID: 5774083
[No Abstract] [Full Text] [Related]
6. Status of problem of usage of tolbutamide. Preliminary statements.
Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
[No Abstract] [Full Text] [Related]
7. Long-term results with oral hypoglycemic drugs.
Moss JM; DeLawter DE
J Am Geriatr Soc; 1973 Feb; 21(2):72-6. PubMed ID: 4688111
[No Abstract] [Full Text] [Related]
8. Comparison of acetohexamide with other sulfonylurea compounds in the treatment of diabetes mellitus.
Berglund B; Jakobson T
Acta Med Scand; 1965 Dec; 178(6):735-44. PubMed ID: 5855411
[No Abstract] [Full Text] [Related]
9. Insulin-independent diabetes mellitus.
Bricker LA; Mintz DH
Med Clin North Am; 1971 Mar; 55(2):295-304. PubMed ID: 4926053
[No Abstract] [Full Text] [Related]
10. [Use of hypoglycemic sulfonamides in the clinic].
Martin E
Actual Pharmacol (Paris); 1968; 21():191-212. PubMed ID: 4888765
[No Abstract] [Full Text] [Related]
11. [Side-effects of oral antidiabetics].
Yawata M; Morita T
Nihon Rinsho; 1968 Jul; 26(7):1627-32. PubMed ID: 4884329
[No Abstract] [Full Text] [Related]
12. Single and combined drug therapy of sulfonylurea failure.
Abelove WA; Echenique R
J Fla Med Assoc; 1969 Apr; 56(4):262-3. PubMed ID: 5776594
[No Abstract] [Full Text] [Related]
13. Tolanase - a sulphonylurea antidiabetic agent.
Drug Ther Bull; 1968 Mar; 6(7):27-8. PubMed ID: 5655488
[No Abstract] [Full Text] [Related]
14. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
Schmeltz R; Wendorff HJ; Field JB
J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
[No Abstract] [Full Text] [Related]
15. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
SMITH DL; VECCHIO TJ; FORIST AA
Metabolism; 1965 Mar; 14():229-40. PubMed ID: 14261407
[No Abstract] [Full Text] [Related]
16. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.
Tsalikian E; Dunphy TW; Bohannon NV; Lorenzi M; Gerich JE; Forsham PH; Kane JP; Karam JH
Diabetes; 1977 Apr; 26(4):314-21. PubMed ID: 849812
[TBL] [Abstract][Full Text] [Related]
17. [ACTION OF HYPOGLYCEMIC SULFONAMIDES ON THE PRODUCTION OF CO2 BY ADIPOSE TISSUE OF THE RAT EPIDIDYMIS "IN VITRO"].
MARQUES M; RIETCORREA P
Folia Endocrinol; 1964 Jun; 17():381-6. PubMed ID: 14210726
[No Abstract] [Full Text] [Related]
18. Comparision of chlorpropamide with tolazamide in the treatment of diabetes mellitus.
Sherwood G; Bressler R
Curr Ther Res Clin Exp; 1968 Aug; 10(8):399-405. PubMed ID: 4970053
[No Abstract] [Full Text] [Related]
19. Oral treatment in diabetes.
Stowers JM
Clin Endocrinol Metab; 1972 Nov; 1(3):721-50. PubMed ID: 4204135
[No Abstract] [Full Text] [Related]
20. Clinical experience with the oral antidiabetic compound, tolazamide.
McKendry JB; Gfeller KF
Can Med Assoc J; 1967 Mar; 96(9):531-5. PubMed ID: 6019353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
